A CLINICAL STUDY TO EVALUATE THE MADHUMEHAHARA KARMA ANTIHYPEREGLYCEMIC ACTIVITY OF VASA Adhatoda vasica Nees

A CLINICAL STUDY TO EVALUATE THE MADHUMEHAHARA KARMA (ANTIHYPEREGLYCEMIC ACTIVITY) OF VASA (ADHATODA VASICA)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041178

Enrollment

Registered

2022-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Vasa patra vati: vasa patra vati at the dose of 3grams /day 500miligrams 2 tablets Intervention2: Vasa Vati: 3grams TID for the duration of 30 days Intervention3: vasa vati: 3 grams TID

Eligibility

Inclusion criteria

Inclusion criteria: subjects above 30 years of either gender suffering from Type two Diabetes mellitus Fasting blood sugar more than or equal to 126mg/dL post prandial blood sugar more than equal to 180 mg/dl

Exclusion criteria

Exclusion criteria: Subjects with Diabetes mellitus who are on insulin subjects with Diabetic complications like Diabetic foot, Diabetic retinopathy and other secondary complications

Design outcomes

Primary

Measure	Time frame
any effect on quality of lifeTimepoint: 30 days	—

Secondary

Measure	Time frame
reduction in blood sugar level and reduction in urine sugar levelTimepoint: 30 days;reduction in blood sugar level and urine sugar levelTimepoint: 15th day, 30th day	—

Countries

India

Contacts

Public ContactDr Akshata

SDM college of Ayurveda and Hospital Hassan Hassan

drharini@sdmcahhassan.org9886427831

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026